Google
Trusted Resources: People & Places
Healthcare providers, researchers, and advocates
Sandeep Soni, MD
Researcher Executive Director
CRISPR Therapeutics, Inc.
610 Main Street
Cambridge, Massachusetts, United States
Sandeep Soni, MD, is the Executive Director at CRISPR Therapeutics, Inc. His expertise includes bone marrow transplantation (HSCT), cellular therapies and gene therapy for malignant and non-malignant blood disorders and clinical development of programs. He is also an expert of lentiviral vectors, Crispr- Cas9 gene editing, stem cell transplant, T-cell therapies and regulatory/safety aspects of gene-therapies.
Areas of Interest-
– Cellular Therapy
– Gene Therapy
– Stem Cell Transplant
– Sickle Cell Disease
– Thalassemia
– Reduced Intensity Conditioning
Clinical Focus-
– Hematology/Oncology
– Stem Cell Transplant and Gene Therapy
+myBinderRelated Content
-
PCORI Board Approves $18 Million for Research on Sickle Cell DiseaseThe Patient-Centered Outcomes Research I...
-
Wake Forest University Sickle Cell Center of ExcellenceWake Forest School of Medicine has serve...
-
Kwaku Ohene-Frempong, MD (Remembering)We are devastated to learn of the death ...
-
Data Brief: Healthcare Utilization for Vaso-Occlusive Episodes by People with Sickle Cell Disease in California and ...Many people with sickle cell disease (SC...
-
Shalini Shenoy, MDDr. Shenoy is currently working as profe...
-
Physician Prescribing Practices in Sickle Cell DiseaseSickle cell disease (SCD) affects approx...
-
Today’s Faces of Sickle Cell Disease: Carolyn Rowley, PhDCarolyn Rowley is a psychologist, patien...
